Synthesis of novel thiazolyl hydrazone derivatives as potent dual monoamine oxidase-aromatase inhibitors

dc.authorid0000-0001-7001-0739
dc.authorid0000-0002-7271-6791
dc.authorid0000-0002-8651-826X
dc.contributor.authorEvren, Asaf Evrim
dc.contributor.authorNuha, Demokrat
dc.contributor.authorDawbaa, Sam
dc.contributor.authorSaglik, Begum Nurpelin
dc.contributor.authorYurttas, Leyla
dc.date.accessioned2025-05-20T18:58:23Z
dc.date.issued2022
dc.departmentBilecik Şeyh Edebali Üniversitesi
dc.description.abstractThe inhibitory effects of 2-thiazolyl hydrazones on monoamine oxidase enzymes are known for a long time. In this study, a new series of 2-thiazolyl hydrazone derivatives were synthesized starting from 6-methoxy-2-naphthaldehyde. All of the synthesized compounds were investigated in terms of their monoamine oxidase (MAO) inhibitory effects and significant results were found. The results showed that compound 2j potently inhibited MAO-A and MAO-B, while compound 2t strongly and selectively inhibited MAO-B compared to standard drugs. Compounds 2k and 2q exhibited selective and satisfying inhibition on MAO-B. In the aromatase inhibition studies of the compounds, it was determined that compounds 2q and 2u had high inhibitory properties. Molecular docking studies on MAO-A, MAO-B, and aromatase enzymes were carried out for the aforementioned compounds. Additionally, molecular dy-namics simulation was studied for compound 2q on MAO-B and aromatase complexes. Finally, the Field-based QSAR study was developed and the structure-activity relationship (SAR) was explained. For the first time, dual inhibitors on MAO and aromatase enzyme were investigated together. The aim of this approach is for finding the potential agents that do not cause the cognitive disorders and may even treat neurodegenerative symptoms, thus, the aim was reached successfully. (c) 2021 Elsevier Masson SAS. All rights reserved.
dc.description.sponsorshipAnadolu University Scientific Research Projects [2008S092]; Anadolu University
dc.description.sponsorshipThis research was funded by Anadolu University Scientific Research Projects with grant number 2008S092and The APC was funded by Anadolu University.
dc.identifier.doi10.1016/j.ejmech.2021.114097
dc.identifier.issn0223-5234
dc.identifier.issn1768-3254
dc.identifier.pmid34998057
dc.identifier.scopus2-s2.0-85122248895
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1016/j.ejmech.2021.114097
dc.identifier.urihttps://hdl.handle.net/11552/8292
dc.identifier.volume229
dc.identifier.wosWOS:000769400900008
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWoS
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakWoS - Science Citation Index Expanded
dc.indekslendigikaynakIndex Chemicus (IC)
dc.language.isoen
dc.publisherElsevier France-Editions Scientifiques Medicales Elsevier
dc.relation.ispartofEuropean Journal of Medicinal Chemistry
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250518
dc.subject2-Thiazolylhydrazones
dc.subjectMonoamine oxidase inhibition
dc.subjectAromatase inhibition
dc.subjectMolecular docking
dc.subjectMolecular dynamic simulation
dc.subjectQSAR
dc.titleSynthesis of novel thiazolyl hydrazone derivatives as potent dual monoamine oxidase-aromatase inhibitors
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Makale.pdf
Boyut:
4.13 MB
Biçim:
Adobe Portable Document Format